For the US patent application, they received a “Final Rejection” notice from the examiners on 8th July 2020.
Amendments were submitted by Recce on 7th October 2020, so the jury’s out and we’re at the examiners’ mercy.
You can download all correspondence here:
US20180338994 - ANTI-VIRUS AGENT AND METHOD FOR TREATMENT OF VIRAL INFECTIONUS20180338994 - ANTI-VIRUS AGENT AND METHOD FOR TREATMENT OF VIRAL INFECTION
https://patentscope.wipo.int/search/en/detail.jsf?docId=US234195945
It doesn’t look like they’ve requested examination for the Australian application yet.
They have until 5 years from the filing date to do so.
AU2017220391 - ANTI-VIRUS AGENT AND METHOD FOR TREATMENT OF VIRAL INFECTION
https://patentscope.wipo.int/search/en/detail.jsf?docId=AU215296824
Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program, page-196
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.010(1.96%) |
Mkt cap ! $115.8M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 55.0¢ | 50.0¢ | $168.7K | 317.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6252 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 13561 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |